The successful candidate will break news on an industry that has suffered a major political loss in the United States and is bracing for new federal efforts to bring down the cost of prescription medicines.
This reporter would shed light on the commercial strategies of leading industry players, with a broad view on how new medicines in development will impact companies, investors, patients and providers.
At the same time, the candidate will report on how big pharma companies are turning to deals and new business opportunities after having benefited tremendously from developing vaccines and treatments critical to alleviating the COVID-19 pandemic.
The reporter would demonstrate a track record of deep source development and show how they would cultivate a roster of sources among pharmaceutical and biotech executives, government health officials and industry investors. The preferred location for the role is New York.
About the Role
As our U.S. Pharmaceutical Industry Reporter, you will:
About You
To be our U.S. Pharmaceutical Industry Reporter, you will likely have:
Please note, the deadline for applications is Friday 14th October 2022.
To apply, go here.
The Pacific Business News, an American City Business Journals publication, has hired Janis Magin Meierdiercks as…
Sadia Nowshin, a reporter at European startup news site Sifted, is leaving to join literary…
Variety has promoted Ethan Shanfeld to TV reporter. William Earl of Variety writes, "Shanfeld joins the entertainment…
Kasia Klimasinska is the new team leader for DC breaking news at Bloomberg News. She…
Paul Smalera has organized a gathering of James Ledbetter's friends and colleagues—open to all…
Real estate news service CoStar News has hired Rachel Scheier to cover the San Francisco commercial market.…